Searched for
PFIZER PAPERS
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- India needs to expand local vaccine manufacturing, research: GTRIThe Global Trade Research Initiative (GTRI) urged India to bolster its local vaccine production and research to enhance vaccine safety. The...
- Stock market update: Nifty Pharma index falls 0.26% in an upbeat marketThe Nifty Pharma index was trading 0.26 per cent down at 12743.3.
- Two doses of Covid vaccines induce lower antibody levels against Omicron: Oxford studyTwo doses of Pfizer and AstraZeneca COVID-19 vaccines generate lower levels of antibodies against the Omicron variant of coronavirus, accor...
- Two-dose vaccines induce lower antibodies against Omicron, study findsResearchers from the University of Oxford published results from a study yet to be peer-reviewed, where they analysed blood samples from pa...
- COVID-19 bigger blood clot threat than vaccines, UK study findsThe findings showed although there was an increased risk of having a blood clot after having the first doses of either vaccine, it was much...
- AstraZeneca, Pfizer vaccines effective against Delta COVID-19 variants: StudyThe study by Oxford university investigated the ability of monoclonal antibodies in Sera from recovered people and from vaccinated people t...
- German researchers tie cold viruses used to deliver COVID-19 vaccine to rare blood clot riskThe researchers, in a study not yet reviewed by experts, said COVID-19 vaccines that employ adenovirus vectors - cold viruses used to deliv...
- ‘Two doses key to immunity against Covid variants’A single jab only provided 33% protection against B.1.617.2 and 51% against B.1.1.7, according to the study. The findings were derived from...
- Pfizer, Moderna vaccines may greatly reduce risk of asymptomatic COVID-19 infection, study saysThe Pfizer-BioNTech and Moderna messenger RNA (mRNA) vaccines for COVID-19 are authorised for emergency use in many countries. An mRNA vacc...
- The understated husband-and-wife 'dream team' behind Pfizer's coronavirus vaccinePfizer and BioNTech are the first drugmakers to show successful data from a large-scale clinical trial of a coronavirus vaccine. The compan...
- Germany expects COVID-19 vaccine in Q1 2021 at the earliestThe German government will cover the cost of the vaccines, while the cost of setting up the vaccination centres will be borne by the states...
- Trials and Hopes: Way ahead for Covid-19 treatmentThe leaders of big pharma came together for a joint press conference to give an update on the way ahead for Covid-19 treatment and vaccines...
- Much headway in quest for vaccine: Drugmakers might be one step away from the Covid remedyIn the situation of a grave pandemic engulfing almost all the countries alike, hopes for a cure have brightened with encouraging developmen...
- Stock market update: Over 30 stocks hit 52-week highs on NSEEquity market returned to positive zone after Thursday's losses.
- CEOs of pharma cos to discuss key challenges within industryThe 10th edition of CPhI India, which is touted as South Asia's largest pharma event will take place between November 21 and 23.
- CEOs of pharma companies to discuss key challenges within industryThe 10th edition of CPhI India, which is touted as South Asia's largest pharma event will take place between November 21 and 23.
- Pfizer to buy Allergan in $160 billion deal to create world's No 1 drugmakerNew York-based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allerg...
- Agila Specialties recalls anaesthetic injection in USAgila Specialties, now a part of Mylan Inc, is recalling 10 lots of Etomidate injection, used in general anaesthesia in the US.
- Cipla, Pfizer in talks for supply & production pactCIPLA is in talks to make and supply drugs to global pharmaceutical firm Pfizer as the US-based company plans a foray in the generics busin...
Load More
